PRIMECAP Odyssey Growth (POGRX)

42.11 -0.25  -0.59% Jan 21 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 42.11
Turnover Ratio 6.00%
1 Year Fund Level Flows -1.712B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.56% 5.96% 91
3M 14.73% 12.89% 6
6M 11.63% 11.44% 43
YTD 2.86% 4.59% 85
1Y 17.78% 29.95% 97
3Y 16.06% 18.81% 73
5Y 13.45% 13.59% 52
10Y 14.32% 13.77% 39
15Y 11.44% 9.82% 18
20Y -- 5.97% --
As of Jan. 21, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.19% 2.19% 0.00%
Stock 97.81% 97.81% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2019

Region Exposure

Americas 85.88%
North America 85.88%
Latin America 0.00%
Greater Europe 8.32%
United Kingdom 1.95%
Europe Developed 5.54%
Europe Emerging 0.00%
Africa/Middle East 0.84%
Greater Asia 5.80%
Japan 1.72%
Australasia 0.00%
Asia Developed 1.19%
Asia Emerging 2.89%
Market Classification
% Developed Markets 97.11%
% Emerging Markets 2.89%
As of Sept. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.35%
Communication Services 0.00%
Consumer Cyclical 9.92%
Consumer Defensive 0.07%
Energy 1.89%
Financial Services 9.69%
Healthcare 30.21%
Industrials 16.31%
Real Estate 0.00%
Technology 31.57%
Utilities 0.00%
As of Sept. 30, 2019

Stock Market Capitalization

Giant 31.11%
Large 27.26%
Medium 34.52%
Small 6.94%
Micro 0.17%
As of Sept. 30, 2019

Stock Style Exposure

Large Cap Value 19.33%
Large Cap Blend 21.65%
Large Cap Growth 16.64%
Mid Cap Value 7.24%
Mid Cap Blend 8.49%
Mid Cap Growth 19.41%
Small Cap Value 0.83%
Small Cap Blend 1.49%
Small Cap Growth 4.92%
As of Sept. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
SGEN Seattle Genetics Inc 3.83% 110.43 +1.62%
UAL United Airlines Holdings Inc 3.48% 85.55 -0.28%
PODD Insulet Corp 3.25% 191.51 +0.29%
LLY Eli Lilly and Co 2.69% 140.88 -0.02%
ABMD Abiomed Inc 2.32% 190.03 +0.06%
BABA Alibaba Group Holding Ltd ADR 2.18% 224.48 +1.00%
MU Micron Technology Inc 2.14% 59.49 +0.88%
LUV Southwest Airlines Co 2.09% 53.97 +0.80%
SPLK Splunk Inc 1.98% 157.86 +0.48%
ETFC E*TRADE Financial Corp 1.86% 46.62 +0.21%
As of Sept. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide long-term capital appreciation. The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with the potential for above average earnings growth. It may invest in stocks across all market sectors and market capitalizations. Although it has historically invested primarily in large- and mid-capitalization companies, it has also invested a significant portion of its assets in small-capitalization stocks.
General
Security Type Mutual Fund
Oldest Share Symbol POGRX
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Growth
Prospectus Objective Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Reports
One Page Report Download

Manager Info

Name Tenure
Alfred Mordecai 15.17 yrs
James Marchetti 5.17 yrs
Joel Fried 15.17 yrs
M. Ansari 7.72 yrs
Theo Kolokotrones 15.17 yrs

Net Fund Flows

1M -222.81M
3M -811.03M
6M -1.380B
YTD -1.712B
1Y -1.712B
3Y 1.475B
5Y 2.674B
10Y 4.862B
As of Dec. 31, 2019

Risk Info

Beta (5Y) 1.205
Historical Sharpe Ratio (10Y) 0.9489
Historical Sortino (All) 0.7466
Daily Value at Risk (VaR) 1% (All) 3.35%
Monthly Value at Risk (VaR) 1% (All) 15.22%

Fundamentals

Dividend Yield TTM (1-21-20) 0.48%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 16.89
Weighted Average Price to Sales Ratio 1.623
Weighted Average Price to Book Ratio 2.927
Weighted Median ROE 18.39%
Weighted Median ROA 6.01%
Forecasted Dividend Yield 1.29%
Forecasted PE Ratio 15.54
Forecasted Price to Sales Ratio 1.501
Forecasted Price to Book Ratio 2.421
Number of Holdings 150
As of Sept. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.76%
Forecasted Book Value Growth 3.48%
Forecasted Cash Flow Growth 12.65%
Forecasted Earnings Growth 16.88%
Forecasted Revenue Growth 7.97%
As of Sept. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.